AI assistant
Sending…
PULSE BIOSCIENCES, INC. — Director's Dealing 2019
Mar 19, 2019
32093_dirs_2019-03-19_1463f598-62f4-4e43-a7be-034d5d64a813.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2019-03-18
Reporting Person: Levinson Mitchell E. (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-03-18 | Stock Option (right to buy) | $18.25 | A | 35000 | Acquired | 2029-03-18 | Common Stock (35000) | Direct |
Footnotes
F1: One-third (1/3) of the shares subject to the option will vest on the one-year anniversary of the grant date, and the remaining shares will vest monthly over the following two years, subject to the Reporting Person's continued service through each vesting date.
More from PULSE BIOSCIENCES, INC.
Interim / Quarterly Report
2026
May 14
Proxy Solicitation & Information Statement
2026
May 11
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 16
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 17